361 related articles for article (PubMed ID: 27260943)
1. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
2. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
3. The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct-ligated rats.
Díaz-Gil JJ; García-Monzón C; Rúa C; Martín-Sanz P; Cereceda RM; Miquilena-Colina ME; Machín C; Fernández-Martínez A; García-Cañero R
Histol Histopathol; 2008 May; 23(5):583-91. PubMed ID: 18283643
[TBL] [Abstract][Full Text] [Related]
4. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.
Eshaghian A; Khodarahmi A; Safari F; Binesh F; Moradi A
Br J Nutr; 2018 Aug; 120(4):393-403. PubMed ID: 29880071
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.
Mao Y; Zhang S; Yu F; Li H; Guo C; Fan X
Int J Mol Sci; 2015 Sep; 16(9):21911-30. PubMed ID: 26378522
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner.
Wei Z; Zhao D; Zhang Y; Chen Y; Zhang S; Li Q; Zeng P; Li X; Zhang W; Duan Y; Han J; Yang X
Biochem Biophys Res Commun; 2019 Nov; 519(4):854-860. PubMed ID: 31561855
[TBL] [Abstract][Full Text] [Related]
7. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
[TBL] [Abstract][Full Text] [Related]
8. Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.
Moon JO; Welch TP; Gonzalez FJ; Copple BL
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G582-92. PubMed ID: 19136383
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis.
Türkay C; Yönem O; Arici S; Koyuncu A; Kanbay M
Dig Dis Sci; 2008 Mar; 53(3):789-93. PubMed ID: 17763951
[TBL] [Abstract][Full Text] [Related]
11. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats.
El-Swefy S; Hassanen SI
Ann Hepatol; 2009; 8(1):41-9. PubMed ID: 19221533
[TBL] [Abstract][Full Text] [Related]
12. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
13. Secondary biliary cirrhosis in the rat is prevented by decreasing NF-κB nuclear translocation and TGF-β expression using allopurinol, an inhibitor of xanthine oxidase.
Aldaba-Muruato LR; Moreno MG; Hernández-Mercado E; Shibayama M; Muriel P
Can J Physiol Pharmacol; 2012 Nov; 90(11):1469-78. PubMed ID: 23181275
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
15. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction.
Sui X; Wei H; Wang D
J Cell Mol Med; 2015 Aug; 19(8):1773-82. PubMed ID: 25823960
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
18. Positive Effects of Ger-Gen-Chyn-Lian-Tang on Cholestatic Liver Fibrosis in Bile Duct Ligation-Challenged Mice.
Chang ZY; Chen CC; Liu HM; Yeh YC; Lin TY; Lee TY; Huang TH
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31455001
[TBL] [Abstract][Full Text] [Related]
19. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats.
Canbakan B; Akin H; Tahan G; Tarcin O; Eren F; Atug O; Tahan V; Imeryuz N; Yapicier O; Avsar E; Tozun N
Ann Hepatol; 2009; 8(3):234-40. PubMed ID: 19841503
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).
Abd El Motteleb DM; Ibrahim IAAE; Elshazly SM
Toxicol Appl Pharmacol; 2017 Nov; 335():64-71. PubMed ID: 28974454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
